Skip to main content
Case Reports, Dose Escalation/Reduction, Adverse Events
Dexamethasone-Sparing Strategies Using Netupitant and Palonosetron Fixed-Dose Combination for Prophylaxis of Chemotherapy-Induced Nausea and Vomiting: A Case Series
Volkmar Böhme, MD, Ee Min Yeoh, BSc Pharm
Volkmar Böhme, MD; Ee Min Yeoh, BSc Pharm
Read More
HOPA Abstracts
HOPA 2020 Abstracts, Part III
Read More
Ovarian Cancer
ASCO Guidelines Support PARP Inhibitor Use in Maintenance and Recurrent Setting of Advanced Ovarian Cancer
Read More
Ovarian Cancer
Niraparib Efficacy in Advanced Ovarian Cancer Extends to All Biomarker Subgroups
Read More
Ovarian Cancer
Olaparib/Bevacizumab as First-Line Maintenance Reduces Risk for Progression or Death in Patients with Advanced Ovarian Cancer
Read More
Ovarian Cancer
Online Delivery of Genetic Services: No Increase in Cancer Risk Distress versus Telephone Counseling
Read More
Lung Cancer
Rearrangement During Transfection (RET) Fusions and Their Role as Oncogenic Drivers
Read More
Lung Cancer
Molecular Profiling Is Critical for Optimizing NSCLC Therapy
Read More
Lung Cancer
Response to Immune Checkpoint Inhibitors Among Patients with NSCLC with RET Rearrangements
Read More
Lung Cancer
Clinical Trials of Targeted Therapies in RET-Rearranged NSCLC
Read More
Page 127 of 196
Results 1261 - 1270 of 1954